advertisement

Prostate cancer

05 May 2010

FDA Reviews Side Effects From Prostate Cancer Therapy

Doctors urged to consider risks of hormone treatment, inform patients

This article has not necessarily been edited by Health24.

The agency also recommended that:

  • Patients taking GnRH agonists should be checked regularly for signs of the development of diabetes and cardiovascular disease.
  • Management of cardiovascular risk factors -- including smoking, as well as increases in blood pressure, cholesterol, blood sugar and weight -- should be stressed.
  • Those taking GnRH agonists should not stop the therapy unless instructed by their health-care provider.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.